Insiders / Longitude Capital Partners III, LLC
Longitude Capital Partners III, LLC
CIK 1713663personinsider
Companies
3
First seen
May 6, 2021
Last activity
Apr 29, 2022
Companies
| Company | Shares held | Latest |
|---|---|---|
| Inozyme Pharma, Inc. · INZY | 4,174,379 | — |
| Talaris Therapeutics, Inc. · TALS | 3,220,775 | — |
| Sierra Oncology, Inc. · SRRA | 8,015 | — |
All securities held
3 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Inozyme Pharma, Inc. | Common stock | 4,174,379 |
| Sierra Oncology, Inc. | Common stock | 8,015 |
| Talaris Therapeutics, Inc. | Common stock | 3,220,775 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 25, 2022 | Exercise In-the-money exercise | SRRA Sierra Oncology, Inc. Common Stock | $6.43M | +487K +33.00% | 1,964,771 | low |
| Apr 19, 2022 | Buy Open-market buy | INZY Inozyme Pharma, Inc. Common Stock | $5.00M | +1.4M +48.06% | 4,174,379 | high |
| Feb 2, 2022 | Buy Open-market buy | SRRA Sierra Oncology, Inc. Common Stock | $4.72M | +175K |